Skip to content

Sarepta Therapeutics

US · SRPT #2853 by market cap Listed 1970
13.33 -0.84 -5.93%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:54

Quant vs Street three independent views, side by side

StockVane factor grade
F
Momentum strategy signal
Sell
Analyst consensus
Hold

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 1 upgrade vs 0 downgrades among tracked analyst rating changes.
  • Most recent: Deutsche Bank moved from Sell to Hold on 2026-11-10.

Analyst consensus 15 analysts

Hold
Avg price target 22.33 +67.5%
Price target rangecurrent 13.33
Low5.00
Avg22.33
High38.00
Buy 20% Hold 53% Sell 27%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-13 Piper Sandler -- Hold 20.00
2026-11-10 Deutsche Bank -- Hold 18.00
2026-11-09 Citi -- Sell 13.00
2026-11-09 Barclays -- Hold 20.00
2026-11-06 Wells Fargo -- Buy 38.00
2026-11-06 Piper Sandler -- Hold 20.00
2026-11-06 BofA Securities -- Sell --
2026-11-06 Baird -- Hold 18.00
2026-11-06 Wedbush -- Buy 35.00
2026-11-06 Morgan Stanley -- Hold 25.00
2026-11-06 H.C. Wainwright -- Sell 5.00
2026-11-06 Oppenheimer -- Buy 35.00
2026-11-05 Cantor Fitzgerald -- Hold 21.00
2026-11-02 BofA Securities -- Sell 18.00
2026-10-30 H.C. Wainwright -- Sell 5.00
2026-10-26 Wedbush -- Buy 35.00
2026-10-19 Piper Sandler -- Hold 20.00
2026-10-19 H.C. Wainwright -- Sell 5.00
2026-10-16 Wedbush -- Buy 35.00
2026-10-09 BofA Securities -- Sell 18.00
2026-10-05 H.C. Wainwright -- Sell 5.00
2026-10-02 Wells Fargo -- Buy 38.00
2026-09-30 Wedbush -- Buy 35.00
2026-09-30 J.P. Morgan -- Hold 20.00
2026-09-28 William Blair -- Hold --

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-11-10 Deutsche Bank Sell → Hold 18.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-05 After close ±21.00% +1.42% (in line)
2026/Q2 2026-08-05 After close ±8.02% +5.34% (in line)
2026/Q1 2026-05-06 After close ±9.36% -9.68% (beat)
2025/Q4 2026-02-25 After close ±9.75% -8.01% (in line)
2025/Q3 2025-11-03 After close ±19.50% -33.74% (beat)
2025/Q2 2025-08-06 After close ±12.42% +10.46% (in line)
2025/Q1 2025-05-06 After close ±16.88% -21.45% (beat)
2024/Q4 2025-02-26 After close ±7.93% -3.56% (in line)
2024/Q3 2024-11-06 After close ±9.37% -5.90% (in line)
2024/Q2 2024-08-07 After close ±10.64% -2.61% (in line)
2024/Q1 2024-05-01 After close ±7.20% -0.21% (in line)
2023/Q4 2024-02-28 After close ±7.92% -6.98% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:54:28 · For reference only, not investment advice and not tailored to your situation.

Sarepta Therapeutics discussion 0 comments

Add a comment